Cardioprotective role of peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone in a unique murine model of diabetic cardiopathy.
AIMS: Rosiglitazone (RSZ), a PPARgamma agonist was potent efficacious insulin sensitizing blockbuster drug for treatment of Type 2 diabetes mellitus (T2DM) but the benefit of PPARgamma activation in congestive heart failure (CHF) was controversial. The pr.....